209 related articles for article (PubMed ID: 24686170)
1. LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.
Chong PS; Zhou J; Cheong LL; Liu SC; Qian J; Guo T; Sze SK; Zeng Q; Chng WJ
Cancer Res; 2014 Jun; 74(11):3043-53. PubMed ID: 24686170
[TBL] [Abstract][Full Text] [Related]
2. Phosphatase of regenerating liver-3 is regulated by signal transducer and activator of transcription 3 in acute myeloid leukemia.
Zhou J; Chong PS; Lu X; Cheong LL; Bi C; Liu SC; Zhou Y; Tan TZ; Yang H; Chung TH; Zeng Q; Chng WJ
Exp Hematol; 2014 Dec; 42(12):1041-52.e1-2. PubMed ID: 25139404
[TBL] [Abstract][Full Text] [Related]
3. LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AML.
Zhou J; Chan ZL; Bi C; Lu X; Chong PS; Chooi JY; Cheong LL; Liu SC; Ching YQ; Zhou Y; Osato M; Tan TZ; Ng CH; Ng SB; Wang S; Zeng Q; Chng WJ
Mol Cancer Res; 2017 Mar; 15(3):294-303. PubMed ID: 28011885
[TBL] [Abstract][Full Text] [Related]
4. Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia.
Chong PSY; Zhou J; Chooi JY; Chan ZL; Toh SHM; Tan TZ; Wee S; Gunaratne J; Zeng Q; Chng WJ
Oncogene; 2019 Feb; 38(9):1508-1519. PubMed ID: 30305722
[TBL] [Abstract][Full Text] [Related]
5. A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase.
Zhou J; Toh SH; Chan ZL; Quah JY; Chooi JY; Tan TZ; Chong PSY; Zeng Q; Chng WJ
J Hematol Oncol; 2018 Mar; 11(1):36. PubMed ID: 29514683
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.
Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ
J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054
[TBL] [Abstract][Full Text] [Related]
10. An epigenetic role for PRL-3 as a regulator of H3K9 methylation in colorectal cancer.
Liu Y; Zheng P; Liu Y; Ji T; Liu X; Yao S; Cheng X; Li Y; Chen L; Xiao Z; Zhou J; Li J
Gut; 2013 Apr; 62(4):571-81. PubMed ID: 22345654
[TBL] [Abstract][Full Text] [Related]
11. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.
Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L
J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379
[TBL] [Abstract][Full Text] [Related]
12. Histone post-translational modifications associated to BAALC expression in leukemic cells.
Franzoni A; Passon N; Fabbro D; Tiribelli M; Damiani D; Damante G
Biochem Biophys Res Commun; 2012 Jan; 417(2):721-5. PubMed ID: 22197554
[TBL] [Abstract][Full Text] [Related]
13. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
[TBL] [Abstract][Full Text] [Related]
14. KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia.
Xu X; Nagel S; Quentmeier H; Wang Z; Pommerenke C; Dirks WG; Macleod RAF; Drexler HG; Hu Z
Leuk Lymphoma; 2018 Jan; 59(1):204-213. PubMed ID: 28540746
[TBL] [Abstract][Full Text] [Related]
15. AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia.
Jin W; Wu K; Li YZ; Yang WT; Zou B; Zhang F; Zhang J; Wang KK
Oncogene; 2013 Apr; 32(15):1978-87. PubMed ID: 22641217
[TBL] [Abstract][Full Text] [Related]
16. JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.
Lynch JR; Salik B; Connerty P; Vick B; Leung H; Pijning A; Jeremias I; Spiekermann K; Trahair T; Liu T; Haber M; Norris MD; Woo AJ; Hogg P; Wang J; Wang JY
Leukemia; 2019 Jun; 33(6):1400-1410. PubMed ID: 30622285
[TBL] [Abstract][Full Text] [Related]
17. PRL-3 exerts oncogenic functions in myeloid leukemia cells via aberrant dephosphorylation of stathmin and activation of STAT3 signaling.
Xu J; Wu W; Tang Y; Lin Y; Xue Y; Hu J; Lin D
Aging (Albany NY); 2019 Sep; 11(18):7817-7829. PubMed ID: 31546234
[TBL] [Abstract][Full Text] [Related]
18. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
[TBL] [Abstract][Full Text] [Related]
19. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia.
van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM
Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276
[TBL] [Abstract][Full Text] [Related]
20. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
